CMMB Competitors & Alternatives
Compare Chemomab Therapeutics Ltd DRC with similar stocks in the same industry
Biotechnology
CMMB
Main Stock$1.05
Tradestie Score
50
Market Cap
$13.70M
Analyst Upside
+376.2%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.44
|
$154.27M | - | 62 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.57
|
$133.50M | - | 51 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.77
|
$114.01M | - | 53 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$23.19
|
$110.20M | - | 64 | Compare |
|
ABVC
ABVC BioPharma, Inc. Common Stock
|
$1.05
|
$70.39M | - | 42 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.05
|
$67.94M | - | 57 | Compare |
|
EVAX
Evaxion A/S American Depositary Share
|
$3.04
|
$28.05M | - | 42 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$1.20
|
$12.21M | 2.1 | 42 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$0.37
|
$5.01M | - | 40 | Compare |
|
NMAD
NMAD
|
$3.94
|
- | - | 45 | Compare |
More CMMB Analysis
Data updated: Oct 28, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry